A Curated Platform of Equity & Options Market Intelligence
Select Page

APLS

Search by
TICKER SYMBOL

Apellis Pharmaceuticals Inc

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

57.9

-0.59

(-1.009%)

Volume:

21,585

52 week range:

19.83 - 94.75

Market Cap:

6.982B

Company Description:

apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.